跳至主要内容
临床试验/EUCTR2020-001440-26-ES
EUCTR2020-001440-26-ES进行中(未招募)1 期

Pilot, double-blind clinical trial to evaluate the efficacy and safety of pre-exposure use of hydroxychloroquine versus placebo in the prevention of SARS-CoV-2 (COVID-19) infection in healthcare personnel. - PrevenCOVID-19

Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)0 个研究点目标入组 184 人开始时间: 2020年4月20日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
184

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Healthcare personnel (doctor, nurse, nursing assistant or hospital porter) with risk of exposure to SARS-CoV-2 infected or probably infected patients.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 184
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Age under 18.
  • Weight under 40Kg
  • Contraindications for the use of hydroxychloroquine (allergy, retinal disease, myasthenia gravis...)

研究者

发起方
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)

相似试验